Introduced
Underlined text would be added to current law. Struck-through text would be removed.
| 90R1728 KRM-D | ||
| By: Plesa | H.B. No. 214 |
| A BILL TO BE ENTITLED | |
| AN ACT | |
| relating to the authority of the Cancer Prevention and Research | |
| Institute of Texas to award grants for endometriosis research. | |
| BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: | |
| SECTION 1. Section 102.002, Health and Safety Code, is | |
| amended to read as follows: | |
| Sec. 102.002. PURPOSES. The Cancer Prevention and Research | |
| Institute of Texas is established to: | |
| (1) create and expedite innovation in the area of | |
| cancer research and in enhancing the potential for a medical or | |
| scientific breakthrough in the prevention of cancer and cures for | |
| cancer, including research on whether endometriosis may lead to or | |
| increase the incidence of cancer in humans; | |
| (2) attract, create, or expand research capabilities | |
| of public or private institutions of higher education and other | |
| public or private entities that will promote a substantial increase | |
| in cancer research and in the creation of high-quality new jobs in | |
| this state; and | |
| (3) develop and implement the Texas Cancer Plan. | |
| SECTION 2. Section 102.051(a), Health and Safety Code, is | |
| amended to read as follows: | |
| (a) The institute: | |
| (1) may award [ |
|
| or private persons to implement the Texas Cancer Plan, and may award | |
| [ |
|
| research facilities and collaborations in this state for: | |
| (A) research into the causes of and cures for all | |
| types of cancer in humans, including research on whether | |
| endometriosis leads to or increases the incidence of cancer and the | |
| causes of, biological markers of, and treatment efficacy for | |
| endometriosis; | |
| (B) facilities for use in research into the | |
| causes of and cures for cancer; | |
| (C) research, including translational research, | |
| to develop therapies, protocols, medical pharmaceuticals, or | |
| procedures for the cure or substantial mitigation of all types of | |
| cancer in humans; and | |
| (D) cancer prevention and control programs in | |
| this state to mitigate the incidence of all types of cancer in | |
| humans; | |
| (2) may support institutions of learning and advanced | |
| medical research facilities and collaborations in this state in all | |
| stages in the process of finding the causes of all types of cancer | |
| in humans and developing cures, from laboratory research to | |
| clinical trials and including programs to address the problem of | |
| access to advanced cancer treatment; | |
| (3) may establish the appropriate standards and | |
| oversight bodies to ensure the proper use of funds authorized under | |
| this chapter for cancer research and facilities development; | |
| (4) may employ necessary staff to provide | |
| administrative support; | |
| (5) shall continuously monitor contracts and | |
| agreements authorized by this chapter and ensure that each grant | |
| recipient complies with the terms and conditions of the grant | |
| contract; | |
| (6) shall ensure that all grant proposals comply with | |
| this chapter and rules adopted under this chapter before the | |
| proposals are submitted to the oversight committee for approval; | |
| and | |
| (7) shall establish procedures to document that the | |
| institute, its employees, and its committee members appointed under | |
| this chapter comply with all laws and rules governing the peer | |
| review process and conflicts of interest. | |
| SECTION 3. Section 102.201(c), Health and Safety Code, is | |
| amended to read as follows: | |
| (c) The fund may be used only to pay for: | |
| (1) grants for cancer research and for cancer research | |
| facilities in this state to realize therapies, protocols, and | |
| medical procedures for the cure or substantial mitigation of all | |
| types of cancer in humans, including research on whether | |
| endometriosis leads to or increases the incidence of cancer and the | |
| causes of, biological markers of, and treatment efficacy for | |
| endometriosis; | |
| (2) the purchase, subject to approval by the | |
| institute, of laboratory facilities by or on behalf of a state | |
| agency or grant recipient; | |
| (3) grants to public or private persons to implement | |
| the Texas Cancer Plan; | |
| (4) the operation of the institute; | |
| (5) grants for cancer prevention and control programs | |
| in this state to mitigate the incidence of all types of cancer in | |
| humans; and | |
| (6) debt service on bonds issued as authorized by | |
| Section 67, Article III, Texas Constitution. | |
| SECTION 4. This Act takes effect September 1, 2027. |
Official text from the Texas Legislature. Formatting has been adapted for reading on Ratifi.